Evidence map›Paper›PMID 39078841›Full record

ArticlePLOS global public health2024

Evaluating the impact of COVID-19 on routine childhood immunizations coverage in Zambia.

Kelvin Mwangilwa, Charles Chileshe, John Simwanza, Musole Chipoya, Davie Simwaba, Nathan Kapata, Mazyanga Lucy Mazaba, Nyuma Mbewe, Kapina Muzala, Nyambe Sinyange and 2 more

Abstract read
In one paragraph

Article in PLOS global public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kelvin MwangilwaZambia National Public Health Institute, Kabulonga, Lusaka.ORCID https://orcid.org/0000-0002-5099-3392
Charles ChilesheZambia National Public Health Institute, Kabulonga, Lusaka.
John SimwanzaZambia National Public Health Institute, Kabulonga, Lusaka.
Musole ChipoyaZambia National Public Health Institute, Kabulonga, Lusaka.
Davie SimwabaZambia National Public Health Institute, Kabulonga, Lusaka.
Nathan KapataZambia National Public Health Institute, Kabulonga, Lusaka.
Mazyanga Lucy MazabaZambia National Public Health Institute, Kabulonga, Lusaka.
Nyuma MbeweZambia National Public Health Institute, Kabulonga, Lusaka.ORCID https://orcid.org/0000-0002-3309-0538
Kapina MuzalaZambia National Public Health Institute, Kabulonga, Lusaka.
Nyambe SinyangeZambia National Public Health Institute, Kabulonga, Lusaka.
Isaac FwembaDepartment of Epidemiology and Biostatistics, University of Zambia, Lusaka, Zambia.
Roma ChilengiZambia National Public Health Institute, Kabulonga, Lusaka.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are growing concerns about the comeback of vaccine-preventable diseases. Epidemics exert shocks which affect other health performance indicators such as routine immunizations. Early model forecasts indicate decreased use of immunization services, which puts children at greater risk. Concerns about an increase in morbidity and mortality for illnesses other than COVID-19, particularly in children missing routine vaccinations, are of public health interest. In this study, we evaluate COVID-19 effects on the uptake of routine immunization in Zambia.This was an interrupted time series study. National data on routine immunization coverage between January 2017 and December 2022 were analyzed. Interrupted time series analysis was performed to quantify changes in immunization utilization. To determine if changes in the underlying patterns of utilization of immunization service were correlated with the commencement of COVID-19, seasonally adjusted segmented Poisson regression model was utilised.Utilization of health services was similar with historical levels prior to the first case of COVID-19. There was a significant drop in immunization coverage for measles dose two (RR, 0.59; 95% CI: 0.43-0.80). A decreased slope was observed in immunization coverage of Rotavirus dose one (RR, 0.97; 95% CI: 0.96-0.98) and Rotavirus dose two (RR, 0.97; 95% CI: 0.96-0.98). A growing slope was observed for Oral Poliovirus two (RR, 1.007; 95% CI: 1.004-1.011) and Oral Poliovirus three (RR, 1.007; 95% CI: 1.002-1011). We also observed a growing slope in BCG Bacille Calmette-Guerin (BCG) (RR, 1.001; 95% CI: 1.000-1011) and Pentavalent one (RR, 1.00; 95% CI: 1.001-1008) and three (RR, 1.004; 95% CI: 1.001-1008).The COVID-19 pandemic has had a number of unintended consequences that have affected the use of immunization services. Ensuring continuity in the provision of health services, especially childhood immunization, during pandemics or epidemics is crucial. Therefore, Investing in robust healthcare infrastructure to withstand surges, training and retaining a skilled workforce capable of handling emergencies and routine services simultaneously is very cardinal to avoid vaccine-preventable diseases, causing long-term health effects especially child mortality.

Identifiers

PMID39078841
PMCPMC11288450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.